Byrd, J. C., Wierda, W. G., Schuh, A., Devereux, S., Chaves, J. M., Brown, J. R., . . . Furman, R. R. (2020). Acalabrutinib monotherapy in patients with relapsed/refractory chronic lymphocytic leukemia: Updated phase 2 results. Blood.
Citação norma ChicagoByrd, John C., et al. "Acalabrutinib Monotherapy in Patients With Relapsed/refractory Chronic Lymphocytic Leukemia: Updated Phase 2 Results." Blood 2020.
ציטוט MLAByrd, John C., et al. "Acalabrutinib Monotherapy in Patients With Relapsed/refractory Chronic Lymphocytic Leukemia: Updated Phase 2 Results." Blood 2020.
אזהרה: ציטוטים אלה לעיתים לא מדויקים ב 100%.